Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Christina Economides, MD
Brian Howard, MD
David N. Kenigsberg, MD, FACC
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Jessica Griffiths, PA-C
Anna L. Rourke, NP
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Hongya Chen, PharmD
Jennifer Day, PharmD
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
ATTR-CM Management: Pearls From Recent Clinical Trials and Tailoring Therapy
Marianna Fontana, MD
Ronald Witteles, MD
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, MD, DMSc
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Beyond the Horizon: HELIOS Clinical Trials in ATTR Cardiomyopathy
Beyond BeAT-HF: Integrating Barostim into a Comprehensive HF Program
Dmitry M. Yaranov, MD
Putting Data into Clinical Practice
Pam R. Taub, MD, FACC, FASPC
Steven Yakubov, MD, MSCAI, FACC
New TAVR Data – New TAVR Talk Track
Hemal Gada, MD
Cutting-Edge Trials: TAVR for Small Aortic Annuli
Anene Ukaigwe, MD
Getting SMART about TAVR
Renuka Jain, MD
Roxana Mehran, MD
Ashish Aneja, MD
Deepak Talreja, MD, FACC
Elana Koss, MD
New Hope for TAVR: Overcoming Challenges for Women & Patients With Small Annuli
Challenging TAVR Cases
It’s All About Patient Identification
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli